Skip to content

Study of hand fracture fixation with hand plate system

A Prospective, Single Arm, Post Market Clinical Follow-up (PMCF) Study to Evaluate the Safety and Performance of Hand Plate System - Nil

Status
Recruiting
Phases
Phase 4
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/04/065090
Enrollment
15
Registered
2024-04-02
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S623- Fracture of other and unspecifiedmetacarpal bone

Interventions

Intervention1: Hand plate system - Medical Implant: Plates will be implanted only once and will be there for max. 12 Months Control Intervention1: Not applicable: Not applicable

Sponsors

Auxein Medical Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Both male and female above 18 years to 65 years 2 Patients presenting to Orthopaedic emergency or OPD with Hand Fracture which need internal fixation will be included in the study

Exclusion criteria

Exclusion criteria: 1 Any past or present evidence of infection of the treated joint 2 Physical conditions that would eliminate or tend to eliminate adequate implant support or delayed healing viz blood supply limitations poor skin quality previous or active infections sepsis metabolic diseases etc 3 Signs of any local inflammation 4 Patient susceptibility to allergic reaction to the components of the alloy the implant is manufactured from 5 Mental or neurological conditions which tend to pre empt the patients ability or willingness to restrict activities during the healing period viz Parkinsons disease chronic alcoholism Charcots joints drug abuse mental illness patient noncompliance etc 6 Patients having inadequate tissue coverage over the operative site 7 Patient having Foreign body sensitivity 8 Patient with compromised skin 9 Severe osteopenia and or osteoporosis or the presence of marked or rapid bone absorption metabolic bone disease cancer or any other tumor like condition of the bone which may compromise fixation 10 Patient who is pregnant or intends to become pregnant during the study

Design outcomes

Primary

MeasureTime frame
1 Quality of bone union and deformity correction 2 Improvement in ASSH TAF scaleTimepoint: 6 weeks, 3,6, and 12 Months

Secondary

MeasureTime frame
1 Pain evaluation through VAS 2 Assessment of adverse eventsTimepoint: 6 weeks, 3, 6, and 12 Months

Countries

India

Contacts

Public ContactMr Gaurav Luthra

Auxein Medical Pvt Ltd

clinical2@auxeinmedical.com7419660141

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026